Health tech company OptimizeRx is handing over $95 million to buy out omnichannel marketing and analytics firm Medicx Health as it looks to broaden its scope.

Health tech company OptimizeRx正在移交超过9500万美元以购买omnichannel营销和分析公司Medicx Health，因为它似乎正在扩大其范围。

OptimizeRx, a company that facilitates engagement between biopharmaceutical companies, healthcare professionals and patients, has acquired Medicx and its technology solutions with the intention of integrating them into its existing platform.

OptimizeRx是一家促进生物制药公司，医疗保健专业人员和患者之间互动的公司，已收购Medicx及其技术解决方案，目的是将其整合到现有平台中。

This includes the addition of the Medicx patient and HCP-focused Micro-Neighborhood Targeting Platform, which in essence looks to ensure that ads reach and engage a diverse set of patients.This will be wedded to OptimizeRx’s own HCP-focused Dynamic Audience Activation Platform (DAAP), creating what it calls a “single source of innovative technologies that will enhance the reach and efficacy of healthcare marketing for life sciences organizations,” the company said in a press release..

这包括增加Medicx患者和以HCP为重点的微邻域定位平台，从本质上讲，该平台旨在确保AD接触并吸引多种患者。这将与优化Rx自己的以HCP为中心的动态观众激活平台（DAAP）相结合，创建所谓的“创新技术的单一来源，将提高生命科学组织医疗保健营销的覆盖面和效率”，该公司在新闻稿。。

DAAP uses artificial intelligence and a patent-pending machine learning methodology “not found anywhere else,” according to the company, helping biopharma-focused agencies that are looking to increase physician and patient engagement.

据该公司称，DAAP使用人工智能和正在申请专利的机器学习方法“在其他地方找不到”，帮助以生物制药为重点的机构寻求增加医生和患者的参与度。

“Our acquisition of Medicx is expected to be a major business accelerator for us as it encompasses all three of our growth drivers: expanding our audience, introducing new solutions, significantly opening client penetration and growth opportunities,” said Will Febbo, CEO of OptimizeRx, in the release..

“我们收购Medicx有望成为我们的主要业务加速器，因为它涵盖了我们所有三个增长驱动因素：扩大受众，推出新解决方案，显着开放客户渗透和增长机会，”OptimizeRx首席执行官Febbo说，在发布中。。

“I'm extremely proud of the leading patient-focused omnichannel platform the Medicx team has built, and believe our robust IP, data, and analytics capabilities will unlock significant customer value when coupled with OptimizeRx's DAAP technologies and its industry-leading HCP reach,” added Michael Weintraub, Medicx’s founder and chief..

“我为Medicx团队构建的领先的以患者为中心的全渠道平台感到非常自豪，相信我们强大的IP，数据和分析功能与OptimiRx的DAAP技术及其行业领先的HCP覆盖范围相结合将释放出巨大的客户价值，”Medicx创始人兼首席Michael Weintraub补充说。。

“Integrating with a leading HCP-focused enterprise provides numerous efficiencies, but more importantly positions the combined companies to fulfill a greater vision of building an end-to-end communication platform that can inform and educate both patients and HCPs through a highly targeted and data rich methodology that has never before been brought together in a cohesive way.”.

“与领先的以HCP为重点的企业整合可提供多种效率，但更重要的是，使联合企业能够实现建立端到端通信平台的更大愿景，该平台可通过高度有针对性和数据丰富的方式为患者和HCP提供信息和教育。以前从未以凝聚力的方式汇集在一起​​”。